Clinical Trials Directory

Trials / Conditions / Stage IVB Oropharyngeal Squamous Cell Carcinoma

Stage IVB Oropharyngeal Squamous Cell Carcinoma

10 registered clinical trials studyying Stage IVB Oropharyngeal Squamous Cell Carcinoma.

StatusTrialSponsorPhase
CompletedFiclatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell
NCT03422536
University of ArizonaPhase 2
CompletedNivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carc
NCT03342911
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityPhase 2
CompletedPrepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Can
NCT03032250
Wake Forest University Health SciencesN/A
TerminatedDurvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer
NCT02827838
Wake Forest University Health SciencesEARLY_Phase 1
TerminatedStereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer
NCT02388932
Case Comprehensive Cancer CenterN/A
CompletedReduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advance
NCT02254278
NRG OncologyPhase 2
TerminatedCisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Ne
NCT02196168
National Cancer Institute (NCI)Phase 2
CompletedRadiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer
NCT01932697
Mayo ClinicPhase 2
TerminatedCapecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
NCT01267240
National Cancer Institute (NCI)Phase 2
CompletedTemsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who D
NCT01256385
National Cancer Institute (NCI)Phase 2